Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.

about

Unraveling the complex story of immune responses to AAV vectors trial after trial.Adeno-Associated Virus Neutralizing Antibodies in Large Animals and Their Impact on Brain Intraparenchymal Gene Transfer

P2860

Q40073271-A58C03EC-75C7-4E88-830A-E37A81F6DFD8 Q58584630-C8EA0075-DAF3-4683-AB2E-70D5E2E5A2B9

P2860

Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.

Item

http://www.wikidata.org/entity/Q40354609

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Neutralizing antibodies agains ...... implications for gene therapy.

@en

type

Item

label

Neutralizing antibodies agains ...... implications for gene therapy.

@en

prefLabel

Neutralizing antibodies agains ...... implications for gene therapy.

@en

P1476

Neutralizing antibodies agains ...... implications for gene therapy.

@en

P2093

A Corden

http://www.w3.org/2001/XMLSchema#string

A Cotrim

http://www.w3.org/2001/XMLSchema#string

B Handelman

http://www.w3.org/2001/XMLSchema#string

H Yin

http://www.w3.org/2001/XMLSchema#string

I Alevizos

http://www.w3.org/2001/XMLSchema#string

J A Chiorini

http://www.w3.org/2001/XMLSchema#string

P2860

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.

Cloning and characterization of a bovine adeno-associated virus.

IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer.

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

Antibodies, viruses and vaccines.

Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.

Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.

TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.

Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

P2888

gt.2017.1

P304

241-244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2017.1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083404611

http://www.w3.org/2001/XMLSchema#string

P698

28150697

http://www.w3.org/2001/XMLSchema#string

P921

gene therapy

P932

5810933

http://www.w3.org/2001/XMLSchema#string

Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.

about

P2860

P2860

Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P921

P932